Related Experiment Video
Updated: Mar 19, 2026

13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
12.0K
SARC-T a new physical test for sarcopenia assessment with development, validation and physiological evaluation
Blanca Pedauyé-Rueda1,2, José Luis Maté-Muñoz3, Juan Hernández-Lougedo1,2
1Physiotherapy and Health Research Group (FYSA), Department of Physiotherapy, HM Faculty of Health Sciences, Camilo José Cela University, Madrid, Spain.
Frontiers in Aging
|March 18, 2026
Summary
The Sarcopenia Optoelectronic Chair-Rise Velocity Test (SARC-T) effectively assesses sarcopenia probability and severity. This low-impact tool shows strong correlations with other validated tests, making it a valuable complementary diagnostic aid.
Area of Science:
- Gerontology
- Musculoskeletal Health
- Clinical Diagnostics
Background:
- Sarcopenia, a progressive age-related loss of muscle mass and strength, presents diagnostic challenges due to varying prevalence based on algorithms.
- Muscle power is a key predictor of functional limitations in older adults.
- Existing diagnostic methods for sarcopenia require evaluation for complementary tools.
Purpose of the Study:
- To assess the Sarcopenia Optoelectronic Chair-Rise Velocity Test (SARC-T) as an alternative for probable sarcopenia diagnosis and severity assessment.
- To evaluate the correlation of SARC-T performance with other validated sarcopenia assessment tools.
Main Methods:
- A cross-sectional analysis was performed on residents of elderly care centers.
- Physical tests from the EWGSOP2 2019 algorithm were administered.
- The SARC-T was used to measure chair-rise velocity, alongside physiological monitoring (HR, SBP, SpO2).
Main Results:
- The sarcopenia group exhibited significantly lower physical performance across all tested metrics compared to the non-sarcopenia group.
- The SARC-T demonstrated strong correlations with Handgrip (r=0.800), 5-STST (r=-0.719), and TUG (r=-0.523).
- A moderate correlation was observed between SARC-T and Gait Speed (r=-0.438) in the sarcopenia group.
Conclusions:
- The SARC-T is a safe, accurate, and low-impact tool.
- It serves as a valuable complementary method for assessing sarcopenia probability and severity.
- The test's strong correlation with established measures supports its clinical utility.

